These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 25444632)
1. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy. Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483 [TBL] [Abstract][Full Text] [Related]
3. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora. Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517 [TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study. Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507 [TBL] [Abstract][Full Text] [Related]
6. Incidence of Fluoroquinolone Resistant Aerobic Organisms and Efficacy of Rectal Cleaning in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy. Kongubol P; Santanirand P; Sirisreetreerux P; Viseshsindh W; Sangkum P J Med Assoc Thai; 2016 Jun; 99(6):691-6. PubMed ID: 29901317 [TBL] [Abstract][Full Text] [Related]
7. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy. Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy. Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study. Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300 [TBL] [Abstract][Full Text] [Related]
11. Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. Dai J; Leone A; Mermel L; Hwang K; Pareek G; Schiff S; Golijanin D; Renzulli JF Urology; 2015 Jan; 85(1):8-14. PubMed ID: 25458193 [TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844 [TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital. Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990 [TBL] [Abstract][Full Text] [Related]
14. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272 [TBL] [Abstract][Full Text] [Related]
15. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy. Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546 [TBL] [Abstract][Full Text] [Related]
16. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis. Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123 [TBL] [Abstract][Full Text] [Related]